Cargando…

T Cell Metabolism in Cancer Immunotherapy

Immune checkpoint therapies aiming to enhance T cell responses have revolutionized cancer immunotherapy. However, although a small fraction of patients develops durable anti-tumor responses, the majority of patients display only transient responses, underlying the need for finding auxiliary approach...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aksoylar, Halil-Ibrahim, Tijaro-Ovalle, Natalia M., Boussiotis, Vassiliki A., Patsoukis, Nikolaos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341973/ https://www.ncbi.nlm.nih.gov/pubmed/32642279 http://dx.doi.org/10.20900/immunometab20200020

Ejemplares similares

Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy
por: Le Bourgeois, Thibault, et al.
Publicado: (2018)

Commentary on: Combination of Metabolic Intervention and T Cell Therapy Enhances Solid Tumor Immunotherapy
por: Christofides, Anthos, et al.
Publicado: (2021)

Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease
por: Tijaro-Ovalle, Natalia M., et al.
Publicado: (2019)

SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses
por: Christofides, Anthos, et al.
Publicado: (2022)

Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells
por: Bardhan, Kankana, et al.
Publicado: (2019)

Publisher Correction: Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells
por: Bardhan, Kankana, et al.
Publicado: (2020)

Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation
por: Patsoukis, Nikolaos, et al.
Publicado: (2020)

Effects of PD-1 Signaling on Immunometabolic Reprogramming
por: Boussiotis, Vassiliki A., et al.
Publicado: (2022)

Clinical significance of T cell metabolic reprogramming in cancer
por: Herbel, Christoph, et al.
Publicado: (2016)

Runx1 and Runx3 Are Involved in the Generation and Function of Highly Suppressive IL-17-Producing T Regulatory Cells
por: Li, Lequn, et al.
Publicado: (2012)

Revisiting the PD-1 pathway
por: Patsoukis, Nikolaos, et al.
Publicado: (2020)

Immunometabolic Regulations Mediated by Coinhibitory Receptors and Their Impact on T Cell Immune Responses
por: Patsoukis, Nikolaos, et al.
Publicado: (2017)

Assessment of a multi-cytokine profile by a novel biochip-based assay allows correlation of cytokine profiles with clinical outcomes in adult recipients of umbilical cord blood transplantation
por: Karantanos, Theodoros, et al.
Publicado: (2019)

Immunotherapies for Malignant Glioma
por: Boussiotis, Vassiliki A., et al.
Publicado: (2017)

Structural, biochemical, and functional properties of the Rap1-Interacting Adaptor Molecule (RIAM)
por: Sari-Ak, Duygu, et al.
Publicado: (2022)

PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
por: Patsoukis, Nikolaos, et al.
Publicado: (2015)

Rap1-interacting adapter molecule (RIAM) associates with the plasma membrane via a proximity detector
por: Wynne, Joseph P., et al.
Publicado: (2012)

Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases
por: Ibis, Betul, et al.
Publicado: (2023)

Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2
por: Christofides, Anthos, et al.
Publicado: (2016)

The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
por: Bardhan, Kankana, et al.
Publicado: (2016)

Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies
por: Karantanos, Theodoros, et al.
Publicado: (2017)

The evolving role of tissue-resident memory T cells in infections and cancer
por: Yenyuwadee, Sasitorn, et al.
Publicado: (2022)

Regulation of T Cell Differentiation and Function by EZH2
por: Karantanos, Theodoros, et al.
Publicado: (2016)

Corrigendum: Regulation of T Cell Differentiation and Function by EZH2
por: Karantanos, Theodoros, et al.
Publicado: (2016)

Central Role of Gimap5 in Maintaining Peripheral Tolerance and T Cell Homeostasis in the Gut
por: Endale, Mehari, et al.
Publicado: (2015)

Lipid metabolism in tumor immunology and immunotherapy
por: Duong, Lisa K., et al.
Publicado: (2023)

A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression
por: Mahoney, Kathleen M., et al.
Publicado: (2018)

Activation of PI3K Is Indispensable for Interleukin 7–mediated Viability, Proliferation, Glucose Use, and Growth of T Cell Acute Lymphoblastic Leukemia Cells
por: Barata, Joao T., et al.
Publicado: (2004)

The role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapy
por: Ganjoo, Shonik, et al.
Publicado: (2023)

Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma
por: Yeo, Alan T., et al.
Publicado: (2023)

Prostaglandin E2 promotes survival of naive UCB T cells via the Wnt/β-catenin pathway and alters immune reconstitution after UCBT
por: Li, L, et al.
Publicado: (2014)

Blockade of 6-phosphogluconate dehydrogenase generates CD8(+) effector T cells with enhanced anti-tumor function
por: Daneshmandi, Saeed, et al.
Publicado: (2021)

Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy
por: Rangel Rivera, Guillermo O., et al.
Publicado: (2021)

Epigenetic modulation of immunotherapy and implications in head and neck cancer
por: Zhou, Liye, et al.
Publicado: (2021)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
por: Brahmer, Julie R., et al.
Publicado: (2018)

IL-7 and SCF Levels Inversely Correlate with T Cell Reconstitution and Clinical Outcomes after Cord Blood Transplantation in Adults
por: Politikos, Ioannis, et al.
Publicado: (2015)

Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy
por: Cerezo, Michaël, et al.
Publicado: (2020)

Editorial: Targeting Metabolism in Cancer Immunotherapy
por: Roszik, Jason, et al.
Publicado: (2018)

Metabolic Modifications, Inflammation, and Cancer Immunotherapy
por: Zheng, Sihao, et al.
Publicado: (2021)

Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin αIIbβ3
por: Watanabe, Naohide, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_gqtbqdl1l32eku2ebkgg20ii2f